REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC - Amendment
29/04/2021 15:25
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20210429:nBwbctT8Xa&default-theme=true
Form 8.3 - WILLIS TOWERS WATSON PLC - Amendment
Ap19
FORM 8.3 - Amendment to purchase and sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 27 April 2021
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,743,829 1.35% 166,654 0.13%
(2) Derivatives (other than options):
72,359 0.06% 7,134 0.01%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
TOTAL:
1,822,288 1.41% 179,888 0.14%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 35 234.6100 USD
Purchase 50 236.1800 USD
Purchase 50 235.8400 USD
Purchase 59 236.2213 USD
Purchase 91 236.3400 USD
Purchase 100 235.9950 USD
Purchase 100 237.2800 USD
Purchase 100 236.8800 USD
Purchase 101 235.0426 USD
Purchase 134 236.2700 USD
Purchase 139 236.3941 USD
Purchase 139 236.0913 USD
Purchase 146 235.3932 USD
Purchase 191 230.8100 USD
Purchase 198 235.2449 USD
Purchase 200 236.3900 USD
Purchase 326 235.1633 USD
Purchase 715 236.6269 USD
Purchase 900 234.8828 USD
Purchase 900 236.4677 USD
Purchase 1,043 236.2474 USD
Purchase 1,680 236.4805 USD
Purchase 1,687 235.5458 USD
Purchase 2,254 236.5401 USD
Purchase 2,512 235.2674 USD
Purchase 2,869 235.0323 USD
Purchase 2,887 235.9554 USD
Purchase 3,883 236.3001 USD
Purchase 4,125 235.1771 USD
Purchase 4,932 236.2146 USD
Purchase 4,994 235.8600 USD
Purchase 5,852 235.1319 USD
Purchase 6,236 236.2500 USD
Purchase 7,049 234.9743 USD
Purchase 16,749 235.5709 USD
Purchase 21,282 236.2598 USD
Sale 8 236.3400 USD
Sale 9 236.3900 USD
Sale 24 236.1400 USD
Sale 36 236.4475 USD
Sale 45 236.5480 USD
Sale 45 236.5380 USD
Sale 46 236.2371 USD
Sale 63 236.5607 USD
Sale 81 236.6633 USD
Sale 90 236.5235 USD
Sale 99 236.4177 USD
Sale 117 236.4715 USD
Sale 126 236.3707 USD
Sale 191 230.8100 USD
Sale 192 236.4300 USD
Sale 200 236.7150 USD
Sale 200 235.6612 USD
Sale 400 233.3925 USD
Sale 738 236.6312 USD
Sale 840 236.4805 USD
Sale 992 236.4808 USD
Sale 1,612 235.6866 USD
Sale 1,823 236.3537 USD
Sale 1,833 235.5337 USD
Sale 2,254 236.5402 USD
Sale 2,337 236.5401 USD
Sale 2,977 235.2035 USD
Sale 4,218 235.7440 USD
Sale 4,926 235.1994 USD
Sale 8,499 236.2461 USD
Sale 9,601 236.2500 USD
Sale 12,055 235.7193 USD
Sale 17,829 236.2103 USD
Sale 20,000 235.1019 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 29 Apr 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or
Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021
Notes
1. Where there are open option positions or open derivative positions (except
for CFDs), full details should be given. Full details of any existing
agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in
doubt, consult the Panel.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20210429005752/en/
(https://www.businesswire.com/news/home/20210429005752/en/)
BARCLAYS PLC
Copyright Business Wire 2021Recent news on Barclays
See all newsREG - J.P. Morgan Sec PLC - Stabilisation Notice
AnnouncementREG - Barclays PLC IQE PLC - Form 8.3 IQE PLC
AnnouncementREG - Barclays PLC Life Science REIT - Form 8.3 LIFE SCIENCE REIT PLC
AnnouncementREG - Barclays PLC Intertek Group Plc - Form 8.3 INTERTEK GROUP PLC
AnnouncementREG - Barclays PLC Intnl Personal Fin - Form 8.3 INTERNATIONAL PERSONAL FINANCE PLC
Announcement